In-vitro and in-silico evaluations of heterocyclic-containing diarylpentanoids as Bcl-2 inhibitors against LoVo colorectal cancer cells
In the present study, we investigated the in-vitro anti-cancer potential of six diarylpentanoids against a panel of BRAF- and KRAS-mutated colorectal cancer cell lines including T84, SW620, LoVo, HT29, NCI-H508, RKO, and LS411N cells. Structure-activity relationship study suggested that the insertio...
Main Authors: | Leong, Sze Wei, Chia, Suet Lin, Abas, Faridah, Yusoff, Khatijah |
---|---|
Format: | Article |
Language: | English |
Published: |
Multidisciplinary Digital Publishing Institute
2020
|
Online Access: | http://psasir.upm.edu.my/id/eprint/89458/1/LOVO.pdf |
Similar Items
-
In-Vitro and In-Silico Evaluations of Heterocyclic-Containing Diarylpentanoids as Bcl-2 Inhibitors Against LoVo Colorectal Cancer Cells
by: Sze Wei Leong, et al.
Published: (2020-08-01) -
In vitro and in silico evaluations of diarylpentanoid series as a-glucosidase inhibitor
by: Leong, Sze Wei, et al.
Published: (2018) -
Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
by: Wachsberger, P, et al.
Published: (2009) -
Caulerpenyne Affects Bradykinin-Induced Intracellular Calcium Kinetics in LoVo Cells
by: Giovanna Traina
Published: (2021-03-01) -
DDR1 promotes LoVo cell proliferation by regulating energy metabolism
by: Xiong Bin, et al.
Published: (2022-05-01)